Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine
Hepatocellular carcinoma (HCC) remains a global health burden, and is mostly diagnosed at late and advanced stages. Currently, limited and insensitive diagnostic modalities continue to be the bottleneck of effective and tailored therapy for HCC patients. Moreover, the complex reprogramming of metabo...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2023-01-01
|
| Series: | Frontiers in Medical Technology |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fmedt.2022.1065506/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|